Escitalopram in the Treatment of Dysthymic Disorder, Double Blind

Clinical trial NCT00220701 · COMPLETED

Trial details

NCT number: NCT00220701
Sponsor: St. Luke's-Roosevelt Hospital Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Dysthymic Disorder

Start date: 2002-06-01
Primary completion: 2008-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.